Manhattan Borough President Brad Hoylman-Sigal said in an interview that it was his understanding that NYU Langone planned to halt hormone treatments and other "gender-related care" for transgender youth, according to Donald Trump's executive order entitled "Protecting Children from Chemical and Surgical Mutilation." At that time, NYU Langone also canceled appointments for new patients who were scheduled to receive implants that release puberty-blocking medication, the Times noted.
In December 2025, referencing Trump's order, the Department of Health and Human Services (HHS) proposed new rules aimed at ending "the practice of sex-rejecting procedures on children that expose young people to irreversible harm." The proposed rules would block Medicaid funds from going to hospitals that performed "sex-rejecting procedures" on people under the age of 18.
"Under my leadership, and answering President Trump’s call to action, the federal government will do everything in its power to stop unsafe, irreversible practices that put our children at risk," HHS Secretary Robert F. Kennedy Jr. said in a statement. "This Administration will protect America’s most vulnerable. Our children deserve better — and we are delivering on that promise."
In addition to pressure at the federal level, New York recently saw a major lawsuit victory for a woman who sued medical providers for allegedly pushing her to have a double mastectomy when she was 16 years old. A jury in Westchester County awarded Fox Varian $1.6 million for past and future suffering as well as an additional $400,000 for future medical expenses.
Varian argued she was not mentally well or mature enough to make a life-altering medical decision as a minor. The case does not appear related to NYU Langone.
It is unclear how the judgment could shape how New York institutions handle future transgender procedures in the state.
Fox News Digital reached out to NYU Langone Health for comment.
Fox News Digital's Alexander Hall contributed to this report.